Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Top Sell

Security Buy Sell Buy (1M) Sell (1M) ▲ Price Target price Potential
Syros Pharmaceuticals Inc. 9 1 2 0 €1.41 €12.01 751.454%
Aspira Womens Health Inc. 1 1 1 0 €0.83 €4.99 501.494%
Salarius Pharmaceuticals Inc. 0 1 0 0 €0.39 - -
Rocket Pharmaceuticals Inc 2 1 0 0 ? €32.00 99.377%
Enlivex Therapeutics Ltd. 0 1 0 0 €1.10 - -
Cytomx Therapeutics Inc 2 1 0 0 €1.08 €50.00 4521.072%
Intellia Therapeutics Inc 15 1 2 0 €18.85 €60.53 221.189%
Agenus Inc. 4 2 1 0 €0.41 €37.02 8846.834%
Fate Therapeutics Inc. 3 3 0 0 €3.16 €7.31 131.049%
Karyopharm Therapeutics Inc. 8 1 3 0 €0.68 €5.49 711.709%
Atara Biotherapeutics Inc. 2 2 0 0 €0.37 €3.00 716.549%
Coherus Bioscien. 0 2 0 0 €1.19 - -
Xenon Pharmaceuticals Inc. 1 1 0 0 €36.00 €50.00 38.889%
Bellicum Pharmaceuticals Inc. 0 10 0 0 €0.064 - -
Organovo Holdings Inc. 0 9 0 1 €0.50 - -
Minerva Neurosciences Inc. 0 10 0 1 €2.32 - -
Viking Therapeutics Inc 4 1 0 1 €49.45 - -
Trevena Inc. 2 23 0 2 €0.15 €6.48 4136.601%
Cara Therapeutics Inc. 10 7 0 3 €0.29 €4.61 1468.593%
Glycomimetics Inc. 3 7 0 4 €0.14 €9.13 6424.714%